FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreRobert Califf, the head of the Food and Drug Administration, doesn’t seem to be having fun on the job. “I
Read MoreA doctor is injecting a vaccine to a baby boy Karl Tapales | moment | Getty Images Sanofi expects its
Read MoreForget “repeal and replace,” an oft-repeated Republican rallying cry against the Affordable Care Act. House Republicans have advanced a package
Read MoreJuly 20, 2023 2 minutes watch Source/Disclosures sources: Healio Interviews Disclosures: Lio reports no relevant financial disclosures. ADD TOPIC TO
Read MoreSource/Disclosures Published by: sources: Bertagnoli S, et al. Abstract 5988. Presented at: International AIDS Society Conference on HIV Science; July
Read MoreWarning labels are designed to inform consumers about potential risks of using a product, but they have become too prevalent
Read MoreSource/Disclosures Disclosures: Punjabi reports receiving research grant support from Philip-Respironics and ResMed for work unrelated to this manuscript. Please see
Read MoreSource/Disclosures Disclosures: Newman-Toker reports being a former volunteer president and member of the Board of Directors of the Society to
Read MoreIn this aerial image, damage is seen to a Pfizer pharmaceutical factory after a tornado hit the facility two days
Read More